AstraZeneca ends contract sales agreement with PDI
Contract sales-force provider PDI said that its fee-for-service agreements with AstraZeneca would be terminated effective April 30. The termination affects ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.